Renal cell carcinoma (also known as hypernephroma, adenocarcinoma of renal parenchyma, and Grawitz tumor) represents 3% of all adult malignant tumors and occurs in a male-female ratio of 1.5:1.0. Between 6% and 16% of the metastases occur in the head and neck region. Approximately 8% of patients have head and neck metastases as the initial presentation1,2; furthermore, renal cell carcinoma may metastasize many years after a successful nephrectomy.